Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 115170-40-6 | MDL No. : | MFCD06659750 |
Formula : | C7H7BrN2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | UZGNFPCHQUHZAI-UHFFFAOYSA-N |
M.W : | 199.05 | Pubchem ID : | 21964079 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.29 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 47.03 |
TPSA : | 24.92 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.17 cm/s |
Log Po/w (iLOGP) : | 1.68 |
Log Po/w (XLOGP3) : | 1.9 |
Log Po/w (WLOGP) : | 1.24 |
Log Po/w (MLOGP) : | 1.65 |
Log Po/w (SILICOS-IT) : | 2.39 |
Consensus Log Po/w : | 1.77 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.72 |
Solubility : | 0.384 mg/ml ; 0.00193 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.05 |
Solubility : | 1.79 mg/ml ; 0.00899 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.48 |
Solubility : | 0.0653 mg/ml ; 0.000328 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.83 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95.6% | With hydrogen bromide; dihydrogen peroxide In dichloromethane at 25 - 30℃; | a) 16.8g (0.14mol) of 7-azaporphyrin, 24.13g (0.143mol) of 48percent hydrobromic acid, and 260g of methylene chloride were charged into a reaction flask and stirred uniformly to obtain a reaction mixture C;b) The reaction mixture temperature was controlled to 25 ~ 30 ° C, was added dropwise 20percent of 20.20g of hydrogen peroxide to obtain a mixture D;c) mixture D is neutralized with a saturated aqueous solution of 60 g of sodium hydrogen sulfite until the red color in the reaction solution completely disappears, liquid separation, to obtain an organic phase E and an aqueous phase F;d) the organic phase E is washed with water, the amount of water is 200g;e) The organic phase E obtained in the step (d) recovers the dichloromethane solvent to obtain 26.6 g of 5-bromo-7-azaporphyrin product, the yield is 95.6percent, and the product liquid chromatographic purity is ≥99percent; |
86% | With bromine; toluene-4-sulfonic acid In dichloromethane at 20℃; for 8 h; | A mixture of 59 g of the compound prepared in step 2 was prepared7-aza-indolineCrude and6.8 g p-toluenesulfonic acid as well600 mL of dichloromethane1L of four bottles,51.2 g of bromine was added dropwise at room temperature,After dripping at room temperature for 8 h;The reaction solution obtained in Step 3 was washed three times with 0.2 mol / L sodium thiosulfate,The organic phase was dried over anhydrous sodium sulfate,Concentrated 84.8 g of 5-bromo-7-azaindoline product,Yield of about 86percent; |
85% | With pyridine; bromine In dichloromethane at -5 - 0℃; for 2.5 h; | A solution OF BR2 (18.1 ML, 56.2 g, 0. 351 mol) in dry CH2CL2 (250 mL) was added dropwise over a period of 1 h 45 min to a stirred and cooled (-5 C) solution of 2 (42. 22 g, 0.351 mol) in dry CH2CL2 (410 ML)-PYRIDINE (40 mL). The yellow suspension WAS STIRRED AT 0 C for 45 min and poured into A mixture of saturated aqueous NaHCO3 (800 ML) and saturated aqueous NA2S203 (100 mL). Methanol (10 ML) was added and the lower organic layer was separated and dried over MGS04. The aqueous layer was extracted with AcOEt: MEOH=99 : 1 (7x1000 mL). These extracts were also dried with MgSO4. The organic solutions were combined and concentrated to afford 5 (59. 17 g, 85percent), which was used in the next step without further purification. 1H NMR (400 MHz, CDCl3) No. 3. 07 (tt, J = 8.4, 1.1 Hz, 2H), 3.64 (T, J = 8. 4 Hz, 2H), 4.47 (bs, 1H), 7.31 (m, 1H), 7. 85 (dt, J= 2.1, 0.9 Hz, 1H). |
73.65% | With pyridine; bromine In dichloromethane at 0℃; for 2 h; Inert atmosphere | A mixture of 7-azaindoline (4 g, 33.29 mmol), pyridine (4 mL), and DCM (40 mL) was added Br2 (1.72 mL, 33.29 mmol) in DCM (24 mL) using an additional funnel under ice bath in nitrogen and stirred for 2 hours. The reaction was then quenched with water and extracted with ethyl acetate (30 ml x 3). The organic layer was collected, dried over anhydrous MgS04, and concentrated in vacuo to yield a dark brown product, which was purified by a flash column over silica gel (ethyl acetate : n-hexane = 2 : 1, Rf = 0.63) to afford 1 (4.88 g, 73.65percent) as a yellow solid. *H-NMR (500MHZ, CDCI3): δ 3.06 (t, /= 8.5 Hz, 2H), 3.64 (t, /= 8.5 Hz, 2H), 7.31 (s, IH), 7.85 (s, IH). |
48% | Stage #1: With N-Bromosuccinimide In N,N-dimethyl-formamide at 20℃; for 15 h; Stage #2: With sodium hydrogencarbonate In water; N,N-dimethyl-formamide at 0℃; |
Preparation Example R-4. 5-Bromo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine 2,3-Dihydro-1H-pyrrolo[2,3-b]pyridine described in Preparation Example R-3 (15mg, 0.13mmol) and N-bromosuccinimide (24mg, 0.14mmol) were dissolved in N,N-dimethylformamide (0.5mL), and the solution was stirred for 15 hours at room temperature. An aqueous solution of saturated sodium bicarbonate was added to the reaction solution at 0°C, which was then extracted with ethyl acetate, the organic layer was washed with brine and dried over anhydrous magnesium sulfate. The solvent was evaporated in vacuo, the residue was purified by silica gel column chromatography (hexane: ethyl acetate = 5: 1), and the title compound (12mg; 60μmol, 48percent) was obtained as a white solid. 1H-NMR Spectrum (DMSO-d6) δ (ppm): 2.98 (2H, t, J=8.8Hz), 3.48 (2H, t, J=8.8Hz), 6.60 (1 H, s), 7.37 (1 H, d, J=1.1 Hz), 7.71 (1 H, d, J=2.4Hz). |
36% | Stage #1: With N-Bromosuccinimide In N,N-dimethyl-formamide at 20℃; for 2.5 h; Stage #2: With sodium hydrogencarbonate In water; N,N-dimethyl-formamide at 0℃; |
Preparation Example O-1. 2,3-Dihydro-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile 1H-Pyrrolo[2,3-b]pyridine (1.0g, 8.46mmol) and 10percent palladium-carbon (500mg) were dissolved in a mixture of formic acid (10mL) and triethylamine (10mL), and the solution was stirred at 70°C for 17 hours. To this reaction mixture was further added 10percent palladium-carbon (270mg), and the mixture was stirred at 70°C for 2 hours. The reaction mixture was cooled to room temperature, then an aqueous solution of 5N sodium hydroxide was added thereto, the solution was extracted with ethyl acetate and tetrahydrofuran, and the organic layer was dried over anhydrous magnesium sulfate. The solvent was evaporated in vacuo, the residue was purified by silica gel column chromatography (ethyl acetate : methanol = 10 : 1), and 2,3-dihydro-1H-pyrrolo[2,3-b]pyridine (614mg, 5.11mmol, 60percent) was obtained as a pale yellow solid. The resulting 2,3-dihydro-1H-pyrrolo[2,3-b]pyridine (614mg, 5.11mmol) and N-bromosuccinimide (1.09g, 6.13mmol) were dissolved in N,N-dimethylformamide (12mL), and the solution was stirred for 2.5 hours at room temperature. An aqueous solution of saturated sodium bicarbonate was added to the reaction solution at 0°C, which was then extracted with ethyl acetate, the organic layer was washed with brine and dried over anhydrous magnesium sulfate. The solvent was evaporated in vacuo, the residue was purified by NH silica gel column chromatography (hexane : ethyl acetate = 3 : 1), and 5-bromo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine (370mg, 1.86mmol, 36percent) was obtained as a white solid. The resulting 5-bromo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine (345mg, 1.73mmol), zinc cyanide (305mg, 2.60mmol) and tetrakis(triphenylphosphine)palladium(0) (200mg, 0.173mmol) were dissolved in dimethylsulfoxide (7mL), and the solution was stirred at 120°C for 4 hours under nitrogen atmosphere. The reaction solution was cooled to room temperature, water and ethyl acetate were added to the reaction solution, the organic layer was separated, the organic layer was washed with brine and dried over anhydrous magnesium sulfate. The solvent was evaporated in vacuo, the residue was purified by silica gel column chromatography (ethyl acetate), and the title compound (167mg, 1.15mmol, 66percent) was obtained as a light brown solid. 1H-NMR Spectrum (DMSO-d6) δ (ppm) : 3.01 (2H, t, J=8.6Hz), 3.58 (2H, t, J=8.6Hz), 7.46 (1 H, s), 7.63 (1 H, s), 8.10 (1 H, s). |
36% | With N-Bromosuccinimide In N,N-dimethyl-formamide at 20℃; for 2.5 - 15 h; | Preparation Example O-1. 2,3-Dihydro-1H-pyrrolo[2,3-]pyridine-5-carbonitrile 1H-Pyrrolo[2,3-b]pyridine (1.0g, 8.46mmol) and 10percent palladium-carbon (500mg) were dissolved in a mixture of formic acid (10mL) and triethylamine (10mL), and the solution was stirred at 70°C for 17 hours. To this reaction mixture was further added 10percent palladium-carbon (270mg), and the mixture was stirred at 70°C for 2 hours. The reaction mixture was cooled to room temperature, then an aqueous solution of 5N sodium hydroxide was added thereto, the solution was extracted with ethyl acetate and tetrahydrofuran, and the organic layer was dried over anhydrous magnesium sulfate. The solvent was evaporated in vacuo, the residue was purified by silica gel column chromatography (ethyl acetate : methanol = 10 : 1), and 2,3-dihydro-1H-pyrrolo[2,3-b]pyridine (614mg, 5.11mmol, 60percent) was obtained as a pale yellow solid. The resulting 2,3-dihydro-1H-pyrrolo[2,3-b]pyridine (614mg, 5.11mmol) and N-bromosuccinimide (1.09g, 6.13mmol) were dissolved in N,N-dimethylformamide (12mL), and the solution was stirred for 2.5 hours at room temperature. An aqueous solution of saturated sodium bicarbonate was added to the reaction solution at 0°C, which was then extracted with ethyl acetate, the organic layer was washed with brine and dried over anhydrous magnesium sulfate. The solvent was evaporated in vacuo, the residue was purified by NH silica gel column chromatography (hexane : ethyl acetate = 3 : 1), and 5-bromo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine (370mg, 1.86mmol, 36percent) was obtained as a white solid. The resulting 5-bromo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine (345mg, 1.73mmol), zinc cyanide (305mg, 2.60mmol) and tetrakis(triphenylphosphine)palladium(0) (200mg, 0.173mmol) were dissolved in dimethylsulfoxide (7mL), and the solution was stirred at 120°C for 4 hours under nitrogen atmosphere. The reaction solution was cooled to room temperature, water and ethyl acetate were added to the reaction solution, the organic layer was separated, the organic layer was washed with brine and dried over anhydrous magnesium sulfate. The solvent was evaporated in vacuo, the residue was purified by silica gel column chromatography (ethyl acetate), and the title compound (167mg, 1.15mmol, 66percent) was obtained as a light brown solid. 1H-NMR Spectrum (DMSO-d6) δ(ppm) : 3.01 (2H, t, J=8.6Hz), 3.58 (2H, t, J=8.6Hz), 7.46 (1 H, s), 7.63 (1 H, s), 8.10 (1H, s).; Preparation Example R-4.5-Bromo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine 2,3-Dihydro-1H-pyrrolo[2,3-b]pyridine described in Preparation Example R-3 (15mg, 0.13mmol) and N-bromosuccinimide (24mg, 0.14mmol) were dissolved in N,N-dimethylformamide (0.5mL), and the solution was stirred for 15 hours at room temperature. An aqueous solution of saturated sodium bicarbonate was added to the reaction solution at 0°C, which was then extracted with ethyl acetate, the organic layer was washed with brine and dried over anhydrous magnesium sulfate. The solvent was evaporated in vacuo, the residue was purified by silica gel column chromatography (hexane : ethyl acetate = 5 : 1), and the title compound (12mg, 60μmol, 48percent) was obtained as a white solid. 1H-NMR Spectrum (DMSO-d6) δ(ppm) : 2.98 (2H, t, J=8.8Hz), 3.48 (2H, t, J=8.8Hz), 6.60 (1 H, s), 7.37 (1 H, d, J=1.1 Hz), 7.71 (1 H, d, J=2.4Hz). |
35% | Stage #1: With pyridine; bromine In dichloromethane at -10 - 0℃; for 3.75 h; Stage #2: With sodium hydrogencarbonate In dichloromethane; water |
Step 2; A solution of Br2 (2.78 ml, 8.64 g, 54 mmole) in dry dichloromethane (40 ml) was added dropwise over a period of 1 h 45 min to a stirred and cooled (-10°C) solution of 2.3-dihydro-1H-pyrrolo[2,3-b]pyridine (6.5 g,54 mmole) in a mixture of dry dichloromethane (60 ml) and pyridine (6 ml). The suspension was stirred at 0°C for 2 hrs, poured into a mixture of NaHCO3 (120 ml) and saturated aqueous Na2S2O3 (15 ml) and extracted with a solution of ethyl acetate/methanol (3X200 ml). The organic layers were concentrated to afford 3.7 g of 5-bromo- 2,3-dihydro- 1H-pyrrolo[2,3-b]pyridine (2) after purification by flash chromatography using dichloromethane as eluent (35percent yield). 1H NMR (400 MHz, DMSO-D6) δ ppm 2.98 ( t, J = 8.54 Hz, 2H ) 3.48 (t, J=8.55 Hz, 2H) 6.58 (bs, 1 H) 7.37(s,1 H) 7.71 (s,1 H) |
130 kg | at 20 - 30℃; for 5 h; Large scale | Control the temperature below 20 degrees Celsius, dihydro-7-azaindole 120kg dissolved in 1200kg of hydrogen bromide dubbed the solution,Control the temperature of 20-30 degrees Celsius, slowly dropping hydrogen peroxide 120kg, add the continued reaction for 5 hours, and then to the reaction solution by adding sodium hydroxide to adjust, and then filtered, washed, centrifuged 0.5 hours, dried product 130kg dihydro-5-bromine -7-azaindole. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With manganese(IV) oxide In dichloromethane for 72 h; | To a stirred solution of azaindoline 5 (7.00 g, 35.2 mmol) in CH2C12 (664 ML) was added activated MnO2 (3.06 g, 35.2 MMOL), AND PROGRESS of the reaction was monitored BY LH EMR of reaction aliquots. After 3 days the mixture was filtered through A pad of silica, and the pad was washed with EtOAc. The filtrates were concentrated to afford the azaindole 27 (6. 98 g, 100 percent) as A brown solid. 1H NMR data as in Method 1. |
90% | With manganese(IV) oxide In toluene for 4 h; Reflux | The 84.8 g of the 5-bromo-7-azaindoline product obtained in step 4 was dissolved in 400 mL of toluene,221.5 g of manganese dioxide was added,Heating reflux reaction 4h;Step 6) The reaction solution obtained in Step 5 was cooled to room temperature,filter,The filter cake was washed twice with dichloromethane,Combine organic phase,dry,Concentrated 5-bromo-7-azaindole crude product,The product was crystallized from a petroleum ether-ethyl acetate mixed solution of ΡΕ / ΕΑ = 10: 1 to give 75 g of 5-bromo-7-azaindole,Yield 90percent. |
85.43% | With activated carbon fiber catalyst In 5,5-dimethyl-1,3-cyclohexadiene at 100℃; for 8 h; | a) 30g (0.151mol) of 5-bromo-7-azaporphyrin, 60g of activated carbon fiber catalyst, 264g of xylene into the reaction flask, stirring evenly, to obtain a reaction mixture G;b) The reaction mixture G at 100 °C, oxygen flow 200mL/min, reaction 8h, chromatographic monitoring of the disappearance of raw materials;c) Filtration, filter out activated carbon fiber catalyst, obtain organic layer H, recover solvent, get 5-bromo-7-azaindole crude product, recrystallize from methanol to obtain product 25.37g, yield 85.43percent, content ≥99percent . |
82% | at 80 - 90℃; for 2 h; Large scale | To the autoclave was added 100 kg of dihydro-5-bromo-7-azaindole, 100 kg of manganese dioxide and 950 kg of glacial acetic acid,Control the temperature of 80-90 degrees Celsius, reaction 2h, then the reaction solution cooled to 20 degrees Celsius, filtered, washed with water, centrifuged for 0.5 hours, dried product 5 - bromo-7-azaindole 82kg. |
75% | With manganese(IV) oxide In toluene at 90℃; for 2 h; | Step 3; To a stirred solution of 5-bromo- 2,3-dihydro- 1H-pyrrolo[2,3-b]pyridine (3.4 g, 17 mmole) in 30 ml of toluene was added activated MnO2 ( 9.5 g, 100 mmole) and the mixture was heated at 90°C for 2 hrs. Then the reaction mixture was filtered through a pad of celite and washed with dichloromethane. Purification was performed by flash chromatography using dichloromethane as eluent giving 2.5 g of 5-bromo- 1 H-pyrrolo[2,3-b]pyridine (3) (75percent yield). 1H NMR (400 MHz, DMSO-D6) δ ppm 6.46 (dd, J=1.83 Hz , J=1.70 Hz, 1H) 7.55 (t, J=3.05 Hz , 1H) 8.21(d, J=2.32 Hz , 1 H) 8.27(d, J=2.90 Hz , 1 H) 11.87 (bs,1 H) |
44% | With 2,3-dicyano-5,6-dichloro-p-benzoquinone In toluene for 0.666667 h; Heating / reflux | Preparation Example R-5. 5-Bromo-1H-pyrrolo[2,3-b]pyridine 5-Bromo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine (600mg, 3.01 mmol) and 2,3-dichloro-5,6-dicyano-1,4-benzoquinone described in Preparation Example R-4 (753mg, 3.31 mmol) was dissolved in toluene (15mL), and the solution was refluxed for 40 minutes under nitrogen atmosphere. The reaction solution was cooled to room temperature, water and ethyl acetate were added thereto, the organic layer was partitioned, the organic layer was washed with brine and dried over anhydrous magnesium sulfate. The solvent was evaporated in vacuo, the residue was purified by silica gel column chromatography (hexane: ethyl acetate = 5: 1), and the title compound (260mg, 1.32mmol, 44percent) was obtained as a white solid. 1H-NMR Spectrum (DMSO-d6) δ (ppm): 6.40-6.48 (1 H, m), 7.50-7.60 (1 H, m), 8.20 (1 H, s), 8.30 (1 H, s), 11.9 (1H, s). |
44% | With 2,3-dicyano-5,6-dichloro-p-benzoquinone In toluene for 0.666667 h; Heating / reflux | 5-Bromo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine (600mg, 3.01mmol) and 2,3-dichloro-5,6-dicyano-1,4-benzoquinone described in Preparation Example R-4 (753mg, 3.31 mmol) was dissolved in toluene (15mL), and the solution was refluxed for 40 minutes under nitrogen atmosphere. The reaction solution was cooled to room temperature, water and ethyl acetate were added thereto, the organic layer was partitioned, the organic layer was washed with brine and dried over anhydrous magnesium sulfate. The solvent was evaporated in vacuo, the residue was purified by silica gel column chromatography (hexane : ethyl acetate = 5 : 1), and the title compound (260mg, 1.32mmol, 44percent) was obtained as a white solid. 1H-NMR Spectrum (DMSO-d6) δ(ppm) : 6.40-6.48 (1 H, m), 7.50-7.60 (1 H, m), 8.20 (1 H, s), 8.30 (1 H, s), 11.9 (1 H, s). |
[ 183208-34-6 ]
5-Bromo-1H-pyrrolo[2,3-b]pyridin-2-one
Similarity: 0.84
[ 183208-54-0 ]
1-(5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-N,N-dimethylmethanamine
Similarity: 0.84
[ 183208-35-7 ]
5-Bromo-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.81
[ 129686-16-4 ]
6-Bromo-3,4-dihydro-1H-[1,8]naphthyridin-2-one
Similarity: 0.79
[ 183208-22-2 ]
5-Bromo-1-methyl-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.78
[ 10592-27-5 ]
2,3-Dihydro-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.84
[ 183208-34-6 ]
5-Bromo-1H-pyrrolo[2,3-b]pyridin-2-one
Similarity: 0.84
[ 183208-54-0 ]
1-(5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-N,N-dimethylmethanamine
Similarity: 0.84
[ 183208-35-7 ]
5-Bromo-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.81
[ 129686-16-4 ]
6-Bromo-3,4-dihydro-1H-[1,8]naphthyridin-2-one
Similarity: 0.79